Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

KalVista Pharmaceuticals (KALV) Shares Issued (2018 - 2025)

KalVista Pharmaceuticals' Shares Issued history spans 7 years, with the latest figure at $295000.0 for Q4 2024.

  • For Q4 2024, Shares Issued rose 130.47% year-over-year to $295000.0; the TTM value through Apr 2025 reached $99.6 million, up 3.02%, while the annual FY2025 figure was $55.9 million, 42.33% down from the prior year.
  • Shares Issued for Q4 2024 was $295000.0 at KalVista Pharmaceuticals, down from $3.0 million in the prior quarter.
  • Across five years, Shares Issued topped out at $96.3 million in Q2 2024 and bottomed at -$11.2 million in Q2 2020.
  • The 3-year median for Shares Issued is $204000.0 (2023), against an average of $12.7 million.
  • The largest annual shift saw Shares Issued crashed 11419.19% in 2020 before it skyrocketed 1370.59% in 2024.
  • A 3-year view of Shares Issued shows it stood at $46000.0 in 2020, then soared by 178.26% to $128000.0 in 2023, then skyrocketed by 130.47% to $295000.0 in 2024.
  • Per Business Quant, the three most recent readings for KALV's Shares Issued are $295000.0 (Q4 2024), $3.0 million (Q3 2024), and $96.3 million (Q2 2024).